These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1152 related articles for article (PubMed ID: 12527755)
21. Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages. Hedl M; Abraham C J Biol Chem; 2011 Jul; 286(30):26440-9. PubMed ID: 21659536 [TBL] [Abstract][Full Text] [Related]
22. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523 [TBL] [Abstract][Full Text] [Related]
23. A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling. McDonald C; Chen FF; Ollendorff V; Ogura Y; Marchetto S; Lécine P; Borg JP; Nuñez G J Biol Chem; 2005 Dec; 280(48):40301-9. PubMed ID: 16203728 [TBL] [Abstract][Full Text] [Related]
24. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. van Heel DA; Ghosh S; Butler M; Hunt KA; Lundberg AM; Ahmad T; McGovern DP; Onnie C; Negoro K; Goldthorpe S; Foxwell BM; Mathew CG; Forbes A; Jewell DP; Playford RJ Lancet; 2005 May 21-27; 365(9473):1794-6. PubMed ID: 15910952 [TBL] [Abstract][Full Text] [Related]
25. Clathrin- and dynamin-dependent endocytic pathway regulates muramyl dipeptide internalization and NOD2 activation. Marina-García N; Franchi L; Kim YG; Hu Y; Smith DE; Boons GJ; Núñez G J Immunol; 2009 Apr; 182(7):4321-7. PubMed ID: 19299732 [TBL] [Abstract][Full Text] [Related]
26. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop. Begue B; Dumant C; Bambou JC; Beaulieu JF; Chamaillard M; Hugot JP; Goulet O; Schmitz J; Philpott DJ; Cerf-Bensussan N; Ruemmele FM J Cell Physiol; 2006 Nov; 209(2):241-52. PubMed ID: 16897777 [TBL] [Abstract][Full Text] [Related]
28. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts. Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140 [TBL] [Abstract][Full Text] [Related]
29. NOD2 modulates immune tolerance via the GM-CSF-dependent generation of CD103 Prescott D; Maisonneuve C; Yadav J; Rubino SJ; Girardin SE; Philpott DJ Proc Natl Acad Sci U S A; 2020 May; 117(20):10946-10957. PubMed ID: 32350141 [TBL] [Abstract][Full Text] [Related]
30. The NOD2-RICK complex signals from the plasma membrane. Lécine P; Esmiol S; Métais JY; Nicoletti C; Nourry C; McDonald C; Nunez G; Hugot JP; Borg JP; Ollendorff V J Biol Chem; 2007 May; 282(20):15197-207. PubMed ID: 17355968 [TBL] [Abstract][Full Text] [Related]
31. pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling. Lee J; Tattoli I; Wojtal KA; Vavricka SR; Philpott DJ; Girardin SE J Biol Chem; 2009 Aug; 284(35):23818-29. PubMed ID: 19570976 [TBL] [Abstract][Full Text] [Related]
32. Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease. van Heel DA; Hunt KA; Ghosh S; Hervé M; Playford RJ Eur J Immunol; 2006 Jun; 36(6):1629-35. PubMed ID: 16637007 [TBL] [Abstract][Full Text] [Related]
33. Muramyl dipeptide potentiates staphylococcal lipoteichoic acid induction of cyclooxygenase-2 expression in macrophages. Ahn KB; Jeon JH; Baik JE; Park OJ; Kang SS; Yun CH; Park JH; Han SH Microbes Infect; 2014 Feb; 16(2):153-60. PubMed ID: 24211871 [TBL] [Abstract][Full Text] [Related]
34. Functional interaction of CARD15/NOD2 and Crohn's disease-associated TNFalpha polymorphisms. Linderson Y; Bresso F; Buentke E; Pettersson S; D'Amato M Int J Colorectal Dis; 2005 Jul; 20(4):305-11. PubMed ID: 15800781 [TBL] [Abstract][Full Text] [Related]
35. RNAi screening identifies mediators of NOD2 signaling: implications for spatial specificity of MDP recognition. Lipinski S; Grabe N; Jacobs G; Billmann-Born S; Till A; Häsler R; Aden K; Paulsen M; Arlt A; Kraemer L; Hagemann N; Erdmann KS; Schreiber S; Rosenstiel P Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21426-31. PubMed ID: 23213202 [TBL] [Abstract][Full Text] [Related]
36. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Ogura Y; Bonen DK; Inohara N; Nicolae DL; Chen FF; Ramos R; Britton H; Moran T; Karaliuskas R; Duerr RH; Achkar JP; Brant SR; Bayless TM; Kirschner BS; Hanauer SB; Nuñez G; Cho JH Nature; 2001 May; 411(6837):603-6. PubMed ID: 11385577 [TBL] [Abstract][Full Text] [Related]
37. Immuno-inhibitory PD-L1 can be induced by a peptidoglycan/NOD2 mediated pathway in primary monocytic cells and is deficient in Crohn's patients with homozygous NOD2 mutations. Hewitt RE; Pele LC; Tremelling M; Metz A; Parkes M; Powell JJ Clin Immunol; 2012 May; 143(2):162-9. PubMed ID: 22397822 [TBL] [Abstract][Full Text] [Related]
38. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043 [TBL] [Abstract][Full Text] [Related]
39. Induction and localization of NOD2 protein in human endothelial cells. Oh HM; Lee HJ; Seo GS; Choi EY; Kweon SH; Chun CH; Han WC; Lee KM; Lee MS; Choi SC; Jun CD Cell Immunol; 2005 Sep; 237(1):37-44. PubMed ID: 16288731 [TBL] [Abstract][Full Text] [Related]
40. Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide. Coulombe F; Divangahi M; Veyrier F; de Léséleuc L; Gleason JL; Yang Y; Kelliher MA; Pandey AK; Sassetti CM; Reed MB; Behr MA J Exp Med; 2009 Aug; 206(8):1709-16. PubMed ID: 19581406 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]